Results 231 to 240 of about 275,080 (334)
Behavioral pharmacology of maprotiline, a new antidepressant
Showa Ueki +5 more
openalex +2 more sources
A new “one‐pot” metal‐free stereoselective method for the synthesis of novel diversely functionalized pyrrolidine‐2‐ones from N‐alkyl‐ or N‐arylsulfonamidoacetophenones was developed. The majority of obtained compounds possess low micromolar antiproliferative activities.
Samuel Dick +7 more
wiley +1 more source
Spravato for Treatment-Resistant Depression: Efficacy and Sexual Side Effect Profile. [PDF]
Raza AA +5 more
europepmc +1 more source
Sciatic Nerve Stimulation Mitigates Depression‐Like Behaviors and Memory Deficits in Stressed Mice
ABSTRACT Stress causes depression and cognitive decline. With limitations in pharmacotherapy, sciatic nerve stimulation (SNS) offers a promising nondrug alternative. This study aimed to explore the therapeutic efficacy of SNS in mitigating stress‐induced depressive behaviors and memory deficits by focusing on astrocytic dysfunction and cellular ...
Chih‐Hao Tien +10 more
wiley +1 more source
Nefazodone shortage in the United States: analysis of drug switching and utilization. [PDF]
Tabah A, Fox J, English C.
europepmc +1 more source
ABSTRACT Inflammation is a common mediator of pancreatic cancer and depression. This study investigated the predictive value and clinical associations of inflammatory markers and depression in cancer patients using machine learning (ML) and statistical modeling.
Yang‐Chen Shen +5 more
wiley +1 more source
Bidirectional Associations Between Tinnitus Subtypes and Psychiatric Conditions
ABSTRACT Objective To evaluate the temporal and bidirectional relationships between tinnitus subtypes—pulsatile tinnitus (PT) and non‐pulsatile tinnitus (NPT)—and psychiatric conditions, specifically generalized anxiety disorder (GAD) and major depression (MD).
Daniel Karasik +4 more
wiley +1 more source
The Effect of ABCB1 Polymorphisms on the Efficacy of Antidepressants. [PDF]
Thorsen SV +3 more
europepmc +1 more source
Prospective study from April 2021 to August 2024 of adult patients with refractory chronic cough undergoing SLN block. This prospective assessment indicates that nearly 2 in 3 refractory chronic cough patients respond positively at 2 weeks post injection, with around 50% of these initial improvers endorsing ongoing cough symptom improvement at 6–9 ...
Andrew T. Peachman +5 more
wiley +1 more source
Co-prescribing of antidepressants and opioids for non-cancer pain in England, 2010-2019: a descriptive study using CPRD primary care electronic health records. [PDF]
Butler J +9 more
europepmc +1 more source

